RxDoctor Payments Data

Steven Quam, DO

Pain Medicine · West Des Moines, IANPI 1780681551

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Nevro Corp. at 25.2% of the total. Reporting peaked in 2019 at $512 and has fallen 61.8% since, to $196 in 2025. That places this record below the midpoint for pain medicine clinicians in IA, where the typical reported total is $2,859.

$1,288in general payments, 2019–2025

Across 57 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$324
  • Vertex$193
  • Pfizer$157
  • Si-bone, Inc.$84
  • Supernus Pharmaceuticals, Inc.$82
  • Teva Pharmaceuticals USA, Inc.$81
  • plus $367 from 13 others

What the payments were for

  • Food & beverage$1,288100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,288 in reported general payments places this provider in the 40th percentile of 31 pain medicine providers in Iowa.

See all pain medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$55,203
Medicare patients
282
Services billed
1,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$6,054
Fentanyl11$2,647
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$2,101
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$1,762
Morphine Sulfate ErMorphine Sulfate30$1,101
Gabapentin75$946
Oxycodone Hcl21$431
Cyclobenzaprine Hcl29$333
Tramadol Hcl34$279
Duloxetine Hcl25$244
Tizanidine Hcl24$194
Naproxen11$167
Methylprednisolone19$166
Pregabalin17$142
Meloxicam13$38

Paid to pharmacies, not to this prescriber.

Other pain medicine in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →